Why the study?
Does aspirin use reduce the risk of MACCE in patients with Takotsubo Syndrome?
Does aspirin use reduce the risk of MACCE in patients with Takotsubo Syndrome?
Aspirin use in patients with Takotsubo Syndrome does not appear to be associated with a reduced risk of MACCE at 30 days or 5 years.
Answers are grounded in this paper and cite their sources.
Does not support aspirin for MACCE prevention in TTS; hypothesis-generating and requires randomized trials.
In the present study, no association was found between aspirin use in TTS patients and a reduced risk of MACCE at 30-day and 5-year follow-up. These findings should be confirmed in adequately powered randomized controlled trials. ClinicalTrials.gov Identifier: NCT01947621.
No takes yet. Share an insight, caveat, or question.
D’Ascenzo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: